反向肩关节置换术中骨植骨治疗严重肩胛盂缺损的功能与影像学结果:至少5年随访
该研究纳入2008至2018年因严重肩胛盂缺损在反向肩关节置换术(RSA)中接受骨植骨且随访至少5年的患者,最终37肩获得随访(随访率90%,平均6.8±2.4年)。整体基座5年生存率为78.4%;初次RSA联合自体骨植骨生存率95%,翻修RSA联合异体骨重建生存率58.8%,翻修手术与更高的基座失败率相关(p=0.014)。
要点
- 严重肩胛盂缺损RSA骨植骨后基座5年总体生存率为78.4%。
- 初次RSA联合自体骨植骨生存率95%,翻修RSA联合异体骨重建生存率58.8%。
- 翻修手术基座失败率41.2%(7/17)高于初次手术5%(1/20),p=0.014。
核心结论
- 严重肩胛盂缺损行RSA联合骨植骨的中期随访基座总体生存率为78.4%。
- 初次RSA联合自体骨植骨重建生存率达95%,而翻修RSA联合异体骨重建生存率较差(58.8%)。
- 尽管初次RSA联合自体骨重建成功率高,但使用中心柱基座的翻修RSA联合异体骨重建基座失败率升高,作者认为应考虑翻修RSA的替代手术方案。
研究设计与样本
- 纳入2008至2018年因严重肩胛盂缺损在RSA中接受骨植骨且随访至少5年的所有患者,为治疗性研究,证据等级III级。
- 56肩接受骨植骨,14肩因患者死亡无法获取、1肩因感染排除,41肩可供随访,其中4肩失访,最终随访率90%(37/41),平均随访6.8±2.4年。
- 37肩中翻修手术17肩、初次手术20肩;自体肱骨头植骨16肩,异体股骨头植骨21肩。
主要发现
- 总体8个基座失败:异体骨组21肩中7肩失败(33.3%),自体骨组16肩中1肩失败(6.3%),p=0.104。
- 翻修手术基座失败7/17(41.2%),初次手术1/20(5%),翻修手术与更高的基座失败率相关(p=0.014)。
- 基座失败平均时间2.1±1.5年,其中2例在术后4年后发生失败。
- 男性及较低的Charlson合并症指数与基座失败相关(均p<0.05)。
- 5年基座总体生存率为78.4%。
临床怎么用
- 作者认为,尽管初次RSA联合自体骨重建成功率高,但使用中心柱基座的翻修RSA联合异体骨重建基座失败率升高,应考虑翻修RSA的替代手术方案。
局限性
- 56肩中14肩因患者死亡无法获取随访、1肩因感染排除、4肩失访,最终随访率为90%(37/41)。
- 异体骨组与自体骨组基座失败率比较p=0.104,未达统计学显著。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The outcomes of bone grafting for severe glenoid defects in reverse shoulder arthroplasty (RSA) are unpredictable. The purpose of this study was to describe the intermediate-term outcomes of glenoid bone grafting in RSA for severe glenoid defects utilizing a baseplate with a long central post. METHODS: All patients who underwent glenoid bone grafting for severe glenoid defects during RSA from 2008 to 2018, with a minimum of 5-year follow-up, were included. Preoperative, immediate postoperative, and minimum 5-year postoperative American Shoulder and Elbow Surgeons (ASES) scores and visual analog scale (VAS) pain scores and radiographs were obtained and reviewed. Baseplate failure was defined as gross radiographic baseplate cutout or baseplate revision due to implant loosening. RESULTS: Of the 56 shoulders that underwent bone grafting, 14 were not available because the patients had died and 1 was excluded because of infection, leaving 41 shoulders available for follow-up. There were 4 shoulders in which the patients were lost to follow-up; therefore, the final follow-up rate was 90% (37 of 41) at a mean of 6.8 ± 2.4 years. There were 17 revision procedures and 20 primary procedures performed. Autograft humeral head was utilized in 16 shoulders, and femoral head allograft was utilized in 21 shoulders. Overall, 8 baseplates failed (allograft, 7 [33.3% failure] of 21; autograft, 1 [6.3% failure] of 16; p = 0.104). Revision surgery (7 [41.2%] of 17) was associated with a higher rate of baseplate failure (p = 0.014) than primary procedures (1 [5%] of 20). The mean time to baseplate failure was 2.1 ± 1.5 years, with 2 cases having failure after 4 years postoperatively. Male sex and a lower Charlson Comorbidity Index were associated with baseplate failure (all p < 0.05). The 5-year overall baseplate survivorship was 78.4%. CONCLUSIONS: Glenoid bone grafting with RSA for severe glenoid defects had an overall baseplate survivorship rate of 78.4% at the intermediate-term follow-up. Primary RSA with autografting for severe defects yielded survivorship of 95%, whereas revision RSA with allograft reconstruction had poorer survivorship (58.8%). Although primary RSA with autograft reconstruction resulted in a high success rate, revision RSA with allograft reconstruction using a central-post baseplate had an elevated baseplate failure rate and alternative surgical solutions for revision RSA should be considered. LEVEL OF EVIDENCE: Therapeutic Level III . See Instructions for Authors for a complete description of levels of evidence.
引用
- Da Silva A, Moverman MA, McCutcheon C, et al. Functional and Radiographic Outcomes of Bone Grafting for Severe Glenoid Defects in Reverse Shoulder Arthroplasty: A Minimum 5-Year Follow-up. J Bone Joint Surg Am. 2025. PMID: 40435212. doi:10.2106/JBJS.24.01052
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。